1. Home
  2. BLRX vs BEST Comparison

BLRX vs BEST Comparison

Compare BLRX & BEST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLRX
  • BEST
  • Stock Information
  • Founded
  • BLRX 2003
  • BEST 2007
  • Country
  • BLRX Israel
  • BEST China
  • Employees
  • BLRX N/A
  • BEST N/A
  • Industry
  • BLRX Biotechnology: Pharmaceutical Preparations
  • BEST
  • Sector
  • BLRX Health Care
  • BEST
  • Exchange
  • BLRX Nasdaq
  • BEST Nasdaq
  • Market Cap
  • BLRX 36.0M
  • BEST 53.1M
  • IPO Year
  • BLRX 2011
  • BEST N/A
  • Fundamental
  • Price
  • BLRX $0.20
  • BEST $2.62
  • Analyst Decision
  • BLRX Strong Buy
  • BEST
  • Analyst Count
  • BLRX 2
  • BEST 0
  • Target Price
  • BLRX $5.50
  • BEST N/A
  • AVG Volume (30 Days)
  • BLRX 1.7M
  • BEST 21.9K
  • Earning Date
  • BLRX 11-25-2024
  • BEST 12-31-2024
  • Dividend Yield
  • BLRX N/A
  • BEST N/A
  • EPS Growth
  • BLRX N/A
  • BEST N/A
  • EPS
  • BLRX N/A
  • BEST N/A
  • Revenue
  • BLRX $21,991,000.00
  • BEST $1,183,106,017.00
  • Revenue This Year
  • BLRX N/A
  • BEST N/A
  • Revenue Next Year
  • BLRX N/A
  • BEST N/A
  • P/E Ratio
  • BLRX N/A
  • BEST N/A
  • Revenue Growth
  • BLRX N/A
  • BEST 11.57
  • 52 Week Low
  • BLRX $0.19
  • BEST $1.85
  • 52 Week High
  • BLRX $1.68
  • BEST $2.77
  • Technical
  • Relative Strength Index (RSI)
  • BLRX 25.94
  • BEST 38.28
  • Support Level
  • BLRX $0.23
  • BEST $2.63
  • Resistance Level
  • BLRX $0.56
  • BEST $2.68
  • Average True Range (ATR)
  • BLRX 0.03
  • BEST 0.04
  • MACD
  • BLRX 0.00
  • BEST -0.00
  • Stochastic Oscillator
  • BLRX 11.82
  • BEST 25.00

About BLRX BioLineRx Ltd.

BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has an off-strategy, legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.

About BEST BEST Inc. each representing twenty (20)

BEST Inc is a supply chain company. It provides a New Retail platform that offers technology-enabled integrated solutions such as supply chain management, express delivery, freight, merchandise sourcing, cross-border supply chain, last-mile, financial and value-added services. The Group operates in the following operating segments, Supply chain management services, Freight, Global and Others. The Others category principally relates to cross-border logistic coordination services. The majority of revenue generated from Freight segment.

Share on Social Networks: